ConductScience.org, home

Paper20072833

Dasatinib.

Lindauer M and 1 other. Recent Results Cancer Res, 2010. Cited by 59 papers, by iCite.

Cite this record

ConductScience Library. Dasatinib. Papers, record 20072833. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20072833

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dasatinib.
PubMed
Journal
Recent Results Cancer Res
PubMed
Year
2010
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
59
iCite
Relative citation ratio, by iCite
1.35
iCite
Revised in PubMed
2015-11-19
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lindauer MMarkus
2Hochhaus AAndreas

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Leukemia, Myelogenous, Chronic, BCR-ABL PositiveMajor topic
Precursor Cell Lymphoblastic Leukemia-LymphomaMajor topic
Protein Kinase InhibitorsMajor topic
PyrimidinesMajor topic
ThiazolesMajor topic
Clinical Trials as Topic
Dasatinib
Humans
Oncogene Proteins v-abl
Proto-Oncogene Proteins c-kit
Receptor, Platelet-Derived Growth Factor alpha
src-Family Kinases

Source PubMed

Download CSV of topics

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.

PMIDTitleJournalYearIn PapersSource
42909951Cellular senescence in multiple sclerosis: hallmarks, immunosenescence, and therapeutic implications.Front Immunol2026https://conductscience.org/library/papers/42909951PubMed
41150770Molecular Mechanisms and Clinical Implications of Fibroblast Growth Factor Receptor 2 Signaling in Gastrointestinal Stromal Tumors.Curr Issues Mol Biol2025https://conductscience.org/library/papers/41150770PubMed
40733131Tyrosine Kinase Inhibitors for Gastrointestinal Stromal Tumor After Imatinib Resistance.Pharmaceutics2025https://conductscience.org/library/papers/40733131PubMed
40144337Periorbital edema and phototoxic rash associated with dasatinib: A case report.SAGE Open Med Case Rep2025https://conductscience.org/library/papers/40144337PubMed
40031988Harnessing p53 for targeted cancer therapy: new advances and future directions.Transcription2025https://conductscience.org/library/papers/40031988PubMed
39765417Senescent brain cell types in Alzheimer's disease: Pathological mechanisms and therapeutic opportunities.Neurotherapeutics2025https://conductscience.org/library/papers/39765417PubMed
39005125Impact of Tyrosine Kinase Inhibitors (TKIs) on Growth in Children and Adolescents with Chronic Myeloid Leukemia: A Systematic Review.Curr Pharm Des2024https://conductscience.org/library/papers/39005125PubMed
37679434Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial.Nat Med2023https://conductscience.org/library/papers/37679434PubMed
37089957Analysis of intracellular tyrosine phosphorylation in circulating neutrophils as a rapid assay for the in vivo effect of oral tyrosine kinase inhibitors.Front Pharmacol2023https://conductscience.org/library/papers/37089957PubMed
36915875Biomarker identification of immune-related genes in pheochromocytoma and paraganglioma.Transl Androl Urol2023https://conductscience.org/library/papers/36915875PubMed
36446524Loss of cell-cell adhesion triggers cell migration through Rac1-dependent ROS generation.Life Sci Alliance2023https://conductscience.org/library/papers/36446524PubMed
35129779Transport and metabolism of tyrosine kinase inhibitors associated with chronic myeloid leukemia therapy: a review.Mol Cell Biochem2022https://conductscience.org/library/papers/35129779PubMed
33792436Dasatinib self-assembled nanoparticles decorated with hyaluronic acid for targeted treatment of tumors to overcome multidrug resistance.Drug Deliv2021https://conductscience.org/library/papers/33792436PubMed
30112222Dasatinib-Induced Hypopigmentation in Pediatric Patient with Chronic Myeloid Leukemia: A Case Report and Review of the Literature.Case Rep Dermatol Med2018https://conductscience.org/library/papers/30112222PubMed
29330550A Metabolomics Pilot Study on Desmoid Tumors and Novel Drug Candidates.Sci Rep2018https://conductscience.org/library/papers/29330550PubMed
28684771The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain.Sci Rep2017https://conductscience.org/library/papers/28684771PubMed
26261215Integrated analysis of numerous heterogeneous gene expression profiles for detecting robust disease-specific biomarkers and proposing drug targets.Nucleic Acids Res2015https://conductscience.org/library/papers/26261215PubMed
26187774Emerging Agents for the Treatment of Advanced, Imatinib-Resistant Gastrointestinal Stromal Tumors: Current Status and Future Directions.Drugs2015https://conductscience.org/library/papers/26187774PubMed
26155085Optic neuropathy secondary to dasatinib in the treatment of a chronic myeloid leukemia case.Saudi J Ophthalmol2015https://conductscience.org/library/papers/26155085PubMed
25779657Elevated Src family kinase activity stabilizes E-cadherin-based junctions and collective movement of head and neck squamous cell carcinomas.Oncotarget2015https://conductscience.org/library/papers/25779657PubMed

See all 31 cited byDownload CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20072833

GET https://conductscience.org/api/papers/v1/20072833/cited_by?page=2